好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

To Describe an Atypical Case of Neuroborreliosis with Catastrophic Antiphospholipid Syndrome
Infectious Disease
P2 - Poster Session 2 (2:45 PM-3:45 PM)
059

NA

A 66-year-old-male presented to the hospital with a six-week history of progressive muscle weakness, truncal radicular pain, dysphagia, hypophonia and bulbar weakness.  The neurological exam was notable for asymmetric L sided proximal weakness in the extremities, hyporeflexia and ataxia.

NA

Initial MRI brain and cervical spine were unremarkable. CSF analysis revealed pleocytosis with lymphocytic predominance and elevated protein, suggestive of central nervous system infection. Borrelia Burgdorferi IgG and IgM were positive in both CSF and serum confirming neuroborreliosis, and the patient was treated with ceftriaxone. The patient subsequently developed a deep venous thrombosis in the Left lower extremity followed by pulmonary embolism and encephalopathy. Repeat MRI brain demonstrated bilateral multifocal cerebral and cerebellar acute infarcts and petechial hemorrhage in the temporal lobe. Further workup revealed an occlusion of the right posterior cerebral artery on CT angiography. There was no evidence of endocarditis or thrombus on echocardiogram. CT abdomen identified no malignancy but revealed an additional splenic infarct. Hypercoagulable workup showed positive lupus anticoagulant antibody. Given intravascular thrombosis involving the brain, lungs and spleen within one week in the presence of positive lupus anticoagulant antibody, catastrophic antiphospholipid syndrome was suspected. Patient was treated with a course of intravenous immunoglobulin and plasmapheresis with significant neurological improvement.  

The classic manifestation of neuroborreliosis consists of radiculoneuritis, cranial neuritis and lymphocytic meningitis. Less commonly, peripheral neuropathy and cerebral vasculitis are associated with neuroborreliosis. We present a rare case of catastrophic antiphospholipid syndrome in the setting of systemic inflammatory response to neuroborreliosis. Our patient responded well to the combined therapy of anticoagulation, plasma exchange and intravenous immunoglobulin. This case highlights that neuroinfection can precipitate catastrophic antiphospholipid syndrome and a timely diagnosis and treatment is crucial to reduce the mortality of this fatal disease.

Authors/Disclosures
Ahya S. Ali, MD (Westchester Medical Center)
PRESENTER
Dr. Ali has nothing to disclose.
Yarden Bornovski, MD (Westchester Medical Center) Dr. Bornovski has nothing to disclose.
Serena Wong, MD (Westchester Medical Center) Dr. Wong has nothing to disclose.
Stephanie Gandelman, MD Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Shamik Bhattacharyya, MD, FAAN (Brigham and Women's Hospital) Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Jon Rosenberg, MD Dr. Rosenberg has nothing to disclose.